CYP3A4 and prostate carcinoma: In the present systematic review and meta-analysis, we aimed to assess and highlight the most important polymorphic pharmacogenetic markers of the CYP3A4 gene associated with prostatic neoplasia, particularly with prostate cancer risk in European Caucasians.